20
Chemwerth Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
They are recognized for ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
One of their notable products is DEXMEDETOMIDINE HCL, with a corresponding US DMF Number 24202.
Remarkably, this DMF maintains an Active status since its submission on December 15, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 27, 2013, and payment made on December 17, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II